Zilixir Biotech

China
Shaxi, Fujian, China

Company profile

Zilixir Biotech company profile

Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating the effectiveness of protein design.

Business identity

Contact email
[email protected]
Phone number
400-687-0908
Operating status
Active
Company type
For Profit
Founded
2021-04-21

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$14.1M
Last funding
Series A / $14.1M / 2023-05-25
Last equity funding
Series A / $14.1M
Investors
5
Lead investors
1

Founders and investors

Lead investors

Qingdao Qingchi Venture Capital

Investors

Hongfeng Investment ManagementHuimei CapitalLife CapitalQingdao Qingchi Venture CapitalQ Ventures